VP, Program Management Office

Posted:
9/19/2025, 5:31:16 AM

Location(s):
California, United States ⋅ Acton, Massachusetts, United States ⋅ Massachusetts, United States ⋅ San Diego, California, United States

Experience Level(s):
Expert or higher

Field(s):
Product

Workplace Type:
Hybrid

Company

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable and waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero finger sticks, and is fully controlled by a compatible personal smartphone.

Insulet recently received FDA clearance for its Omnipod 5 for Type 2 Diabetes in the US, making it the first and only Automated Insulin Delivery (AID) system indicated for both Type 1 and Type 2 Diabetes. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

Studies have demonstrated the clinical and lifestyle advantages of insulin pump therapy over multiple daily insulin injections (MDI). However, many people still choose MDI therapy largely due to the complexity, cost, and inconvenience of conventional pump technology. The Omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with insulin- requiring diabetes.

Insulet was founded in 2000 with the mission to improve the lives of people with diabetes and enable customers to enjoy simplicity, freedom, and healthier lives through innovative technology. The Company’s world headquarters and state-of-the-art automated manufacturing facility are located in Acton, Massachusetts with global offices in the U.K., France, Germany, Netherlands, Canada, Mexico, Australia, and the United Arab Emirates. Omnipod products are available in 25 countries around the world.

Insulet recently concluded its ninth consecutive year of 20% or more revenue growth, and more than doubled its intellectual property portfolio over the last year. Insulet is proud to be recognized as a 2024 LinkedIn Top Company in the United States; recognized as a Great Place to Work® in eight international locations in 2023; and ranked as one of America’s most responsible companies by Newsweek for 2025.

For more information, visit: insulet.com and omnipod.com

The Role

The Head of the Program Management Office (PMO) establishes and leads an enterprise PMO that serves growth, technology, and innovation initiatives across the company. This leader evolves our agile delivery model for technology projects and standardizes end-to-end program governance from concept through launch, ensuring disciplined planning, tracking, and execution across hardware, software/cloud/data, regulatory, quality, manufacturing, supply chain, and commercial readiness. The PMO leader is a key partner to the leadership team, partnering with SVP, R&D and SVP, CTO to establish and execute platform approaches to innovation execution. The PMO will also drive measurement and standards of performance for engineering execution, quality, capacity management, and benefits realization aligned to strategic growth objectives.

 

Key Responsibilities

  • Stand up and mature a fit-for-purpose PMO; define operating model, standards, and a unified “One Plan” with an integrated RAIDE (Risks, Assumptions, Issues, Dependencies, Escalations/Decisions) register, stage-gate/NPI governance, and executive reporting cadence.
  • Capacity/Demand Planning: Partner with Growth and Strategy team to understand portfolio requirements, prioritization, scenario planning. Lead capacity/demand balancing; maintain portfolio dashboards with clear forecast, health, and benefits realization metrics.
  • Agile at Scale: Evolve agile practices (e.g., SAFe) across teams; develop and coach communities of practice (RTEs, Scrum Masters, Program Managers); connect PI Planning and ART/solution cadences to stage- gate/design control deliverables.
  • End-to-End Launch Orchestration: hire and coach strong program leaders to integrate engineering, clinical, quality, regulatory, manufacturing, supply chain, and commercial workstreams from idea through design transfer, V&V, limited/ full market release, and post-launch hypercare to ensure on-time, in-scope, high-quality program execution.
  • Measuring execution and driving performance: establish common measurements of velocity, quality, capacity, stage gate execution, on-time launches, R&D vitality, spend tracking and reporting across portfolio.
  • Standards & Compliance: Embed medical device quality and regulatory expectations (e.g., ISO 13485, 21 CFR 820, ISO 14971) into program governance and documentation; ensure design control traceability and audit readiness.
  • Change & Stakeholder Management: Lead change plans; facilitate cross-functional alignment and decision- making; ensure effective cutover, adoption, and value capture.
  • Tooling & Data: Establish the PMO tooling ecosystem (e.g., Smartsheet/MS Project, Jira/Azure , portfolio analytics); drive high-quality status, milestone, dependency, and risk data to enable insight-driven decisions.
  • People & Capability: Recruit, lead, and develop a high-impact PMO team (program/project managers and agile delivery roles); define career paths, competency models, and coaching programs.
  • Establish best-in-class capabilities for all PMO sub-disciplines required to execute Insulet growth portfolio (agile experts, technology program managers, R&D program managers, strategic program leaders).

Qualifications

  • 15+ years in program/portfolio leadership roles delivering complex, cross-functional medical device and/or health technology programs, including hardware/software launches, in highly regulated environment.
  • Leadership experience with scaled global (2000+) technology organizations
  • Proven experience establishing and leading a PMO with measurable improvements in predictability, organizational performance, and time-to-market.
  • Deep knowledge of regulated product development, including design controls, risk management, verification/validation, and market release readiness (ISO 13485, 21 CFR 820, ISO 14971).
  • Demonstrated success implementing agile at scale (e.g., SAFe) and integrating agile ceremonies with stage- gate/NPI governance.
  • Excellence in demand and capacity planning, executive reporting, and stakeholder engagement.
  • Expertise in Industry Project Management Tools such as JIRA, Confluence, MS Project, Excel, Smartsheets
  • Professional certifications (e.g., PMP, PgMP, SAFe SPC/RTE) and Lean/Continuous Improvement exposure.

Preferred

  • Bachelor’s degree in Engineering, Life Sciences, or related field; advanced degree (MBA/MS) a plus.

 

  • Experience leading transformations that span technology, operations, and commercial readiness.
  • Experience with consumer technology development program management and dev ops practices
  • Strong business acumen and financial fluency

Success Measures

  • Lead and mentor a high-performing team of project managers; build operational discipline in portfolio and resource management
  • On-time, in-scope delivery of priority launches and releases in a fast paced, high growth environment; improved schedule predictability (e.g., PI predictability, milestone adherence).
  • Portfolio throughput and cycle time improvements; reduced critical dependency slippage.
  • Quality outcomes: audit-readiness, design control completeness, defect escape reduction, and smoother market release/hypercare.
  • Stakeholder satisfaction, cross-functional engagement, and decision latency reduction.
  • Maturity progression across agile practices and PMO standards (quantified via assessments).
  • Continued high engagement with leaders living Insulet’s Ways of Working (WOW).

Leadership Competencies

  • Execution-oriented, strategic thinker, capable of translating complex technical visions into pragmatic operational plans, driving execution in an efficient and results-oriented way.
  • Transformative leader experienced in driving organizational change, enhancing agility, and cultivating a culture of inclusivity and collaboration within global engineering teams and the broader organization, leveraging diverse perspectives to drive innovation and excellence.
  • Executive presence and enterprise thinking — capable of operating not only as a functional leader, but as a thought partner and contributor to overall company strategy.
  • Strong communicator with exceptional interpersonal skills, adept at influencing stakeholders across boundaries/functions.
  • Global mindset — understands how to build inclusive, high-trust, high-performance cultures across regions and time zones
  • Builder-operator hybrid — equally fluent in strategic architecture design and hands-on technology delivery governance
  • Decisive and adept at navigating complex technical and regulatory challenges, balancing strategic goals with tactical execution.
  • Mission-driven, deeply committed to delivering meaningful patient experiences through technology excellence.

Location: Greater Boston, MA, or San Diego with frequent presence required at Insulet’s Acton headquarters.

Additional Information:

The US base salary range for this full-time position is $0.00 - $0.00. Our salary ranges are determined by role, level, and location. The range displayed on each job posting reflects the minimum and maximum target for new hire salaries for the position in the primary work location in the US. Within the range, individual pay is determined by work location and additional factors, including job-related skills, experience, and relevant education or training. Your Talent Acquisition Specialist can share more about the specific salary range for your preferred location during the hiring process. Please note that the compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits.

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.

We are looking for highly motivated, performance-driven individuals to be a part of our expanding team. We do this by hiring amazing people guided by shared values who exceed customer expectations. Our continued success depends on it!

At Insulet Corporation all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.

Insulet Corporation

Website: https://insulet.com/

Headquarter Location: Bedford, Massachusetts, United States

Employee Count: 501-1000

Year Founded: 2000

IPO Status: Private

Last Funding Type: Post-IPO Debt

Industries: Biotechnology ⋅ Diabetes ⋅ Health Care ⋅ Medical Device